Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Patient”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005985
What this trial is testing

Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Masonic Cancer Center, University of Minnesota 213
Not applicableStudy completedNCT05288491
What this trial is testing

Chinese Adults With Lymphoma

Who this might be right for
Lymphoma
Takeda 934
Not applicableStudy completedNCT05546190
What this trial is testing

Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)

Who this might be right for
Spastic HemiparesisMuscle Spasticity
Ipsen 25
Early research (Phase 1)Looking for participantsNCT06914479
What this trial is testing

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

Who this might be right for
Recurrent Diffuse Hemispheric Glioma, H3 G34-MutantRecurrent Malignant Brain NeoplasmResectable Brain Neoplasm
University of Michigan Rogel Cancer Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT06997588
What this trial is testing

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

Who this might be right for
PIK3CA-related Overgrowth Spectrum (PROS)
Novartis Pharmaceuticals 104
Not applicableUnknownNCT04913597
What this trial is testing

Switching Avatrombopag and Rh-TPO in ITP

Who this might be right for
Corticosteroid-resistant or Relapsed ITP
Peking University People's Hospital 100
Early research (Phase 1)Study completedNCT00003713
What this trial is testing

Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Genzyme, a Sanofi Company 35
Testing effectiveness (Phase 2)Study completedNCT00057980
What this trial is testing

Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Northwestern University 8
Testing effectiveness (Phase 2)Study completedNCT00033462
What this trial is testing

Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+8 more
National Cancer Institute (NCI) 78
Early research (Phase 1)Study completedNCT00047346
What this trial is testing

Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT05081388
What this trial is testing

COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease

Who this might be right for
SARS-CoV-2
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT04552288
What this trial is testing

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Who this might be right for
Solid TumorSolid CarcinomaSolid Tumor, Adult+1 more
Memorial Sloan Kettering Cancer Center 51
Early research (Phase 1)Study completedNCT01132586
What this trial is testing

Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+10 more
National Cancer Institute (NCI) 61
Early research (Phase 1)Active Not RecruitingNCT05238883
What this trial is testing

HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

Who this might be right for
Gastric CancerRenal Cell CarcinomaMelanoma+6 more
HiFiBiO Therapeutics 72
Early research (Phase 1)Study completedNCT00070083
What this trial is testing

Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
British Columbia Cancer Agency
Testing effectiveness (Phase 2)Ended earlyNCT05900050
What this trial is testing

Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®

Who this might be right for
Acute-On-Chronic Liver FailureAscites
Genfit 15
Early research (Phase 1)Study completedNCT03367390
What this trial is testing

An Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)

Who this might be right for
Type1 Diabetes Mellitus
Eli Lilly and Company 30
Not applicableStudy completedNCT05443113
What this trial is testing

Young Pectus Excavatum Patients and Genetic Defects

Who this might be right for
Genetic DiseasePectus ExcavatumChildren, Adult
Erasmus Medical Center 18
Not applicableUnknownNCT03261024
What this trial is testing

Friction Versus Frictionless Mechanics During Maxillary En-masse Retraction in Adult Patients

Who this might be right for
En-masse Retraction , Class I Bimaxillary Protrusion
Cairo University 30
Testing effectiveness (Phase 2)Study completedNCT00107380
What this trial is testing

S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 86
Next Page